Topics

Lucence Company Profile

05:22 EST 21st November 2019 | BioPortfolio

Lucence is a genomic medicine company founded on a vision of a world without avoidable cancer deaths. The company develops non-invasive blood tests that improve cancer detection and treatment selection. Headquartered in Singapore with offices in San Francisco, Hong Kong, and Suzhou, its services are delivered worldwide through a CLIA-certified laboratory. For more information, please visit www.lucencedx.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

MEDx, Lucence collaborate to develop cancer-care tests

MEDx (Suzhou) Translational Medicine has collaborated with genomic medicine company Lucence for the development of cancer-care tests. As part of the strategic partnership, the companies will co-develo...

Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow

Lucence, a genomic medicine company developing blood-based tests for cancer screening and treatment selection, announced this week the close of a $20 million Series A funding round led by IHH Healthca...

MEDx (Suzhou) and Lucence Partner to Co-Develop Cutting-Edge Cancer-Care Tests

MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - today announced an agreement to pursue a strategic partnership in China to co-develop cancer-c...

Partnership to develop CDx for cancer in China

Lucence Diagnostics has entered an agreement with China's MEDx Translational Medicine to develop companion diagnostic cancer  -More- 

Lucence Raises USD $20M Series A Led by IHH Healthcare to Advance Liquid Biopsy for Early Detection of Multiple Cancers

Lucence, a genomic medicine company that invents blood-based tests for cancer screening and treatment selection, announced today the close of USD $20 million in Series A funding. The round was led by...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Lucence

Lucence is a genomic medicine company founded on a vision of a world without avoidable cancer deaths. The company develops non-invasive blood tests that improve cancer detection and treatment selecti...

More Information about "Lucence" on BioPortfolio

We have published hundreds of Lucence news stories on BioPortfolio along with dozens of Lucence Clinical Trials and PubMed Articles about Lucence for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lucence Companies in our database. You can also find out about relevant Lucence Drugs and Medications on this site too.

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...


Corporate Database Quicklinks



Searches Linking to this Company Record